KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Change in Account Payables (2016 - 2025)

Petmed Express' Change in Account Payables history spans 16 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 119.66% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $9.4 million, up 133.52%, while the annual FY2025 figure was -$13.5 million, 320.58% down from the prior year.
  • Change in Account Payables reached $1.2 million in Q4 2025 per PETS's latest filing, up from -$922000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $17.7 million in Q1 2021 to a low of -$14.8 million in Q2 2021.
  • Average Change in Account Payables over 5 years is -$364150.0, with a median of -$292500.0 recorded in 2022.
  • Peak YoY movement for Change in Account Payables: plummeted 1226.35% in 2021, then skyrocketed 3897.33% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at $10.8 million in 2021, then crashed by 96.87% to $337000.0 in 2022, then surged by 3897.33% to $13.5 million in 2023, then crashed by 144.59% to -$6.0 million in 2024, then skyrocketed by 119.66% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Change in Account Payables are $1.2 million (Q4 2025), -$922000.0 (Q3 2025), and -$3.5 million (Q2 2025).